Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
Current Hematologic Malignancy Reports - United States
doi 10.1007/s11899-016-0308-3
Full Text
Open PDFAbstract
Available in full text
Date
February 22, 2016
Authors
Publisher
Springer Science and Business Media LLC